At a glance
- Originator Shire Pharmaceuticals Group
- Developer GSK; Shire
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 06 Jun 1995 New profile
- 06 Jun 1995 Discontinued-Preclinical for HIV infections treatment in United Kingdom (Unknown route)